Log in

NYSEARCA:IHE - iShares US Pharmaceuticals ETF Stock Price, Forecast & News

$161.19
+0.18 (+0.11 %)
(As of 02/16/2020 04:00 PM ET)
Add
Today's Range
$160.72
Now: $161.19
$161.67
50-Day Range
$158.55
MA: $161.55
$165.35
52-Week Range
$136.66
Now: $161.19
$165.70
Volume3,392 shs
Average Volume13,893 shs
Market Capitalization$354.62 million
P/E RatioN/A
Dividend Yield1.39%
BetaN/A
iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund's investment advisor is BlackRock Fund Advisors.

Basic Details

Issuer iShares
Fund NameiShares US Pharmaceuticals ETF
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:IHE
Inception Date5/1/2006
Fund ManagerDiane Hsiung, Jennifer Hsui, Greg Savage, Alan Mason
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkDow Jones US Select Pharmaceuticals Index
CategorySector
FocusHealth Care
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$354.63 million
Average Daily Volume$16,819.10
Discount/Premium0.00%

ETF Expenses

Management Fee0.44%
Other Expenses0.00%
Total Expenses0.44%
Fee Waiver0.00%
Net Expenses0.44%

Administrator, Advisor and Custodian

AdministratorState Street Bank and Trust Company
AdvisorBlackRock Fund Advisors
CustodianState Street Bank and Trust Company
DistributorBlackRock Investments, LLC
Transfer AgentState Street Bank and Trust Company
Trustee
Lead Market MakerIMC Chicago

Receive IHE News and Ratings via Email

Sign-up to receive the latest news and ratings for IHE and its competitors with MarketBeat's FREE daily newsletter.


Geographic Exposure of iShares US Pharmaceuticals ETF (NYSEARCA:IHE)
Currency Exposure of iShares US Pharmaceuticals ETF (NYSEARCA:IHE)
Sector Exposure of iShares US Pharmaceuticals ETF (NYSEARCA:IHE)
Industry Exposure of iShares US Pharmaceuticals ETF (NYSEARCA:IHE)

iShares US Pharmaceuticals ETF (NYSEARCA:IHE) Frequently Asked Questions

What is iShares US Pharmaceuticals ETF's stock symbol?

iShares US Pharmaceuticals ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "IHE."

How often does iShares US Pharmaceuticals ETF pay dividends? What is the dividend yield for iShares US Pharmaceuticals ETF?

iShares US Pharmaceuticals ETF declared a quarterly dividend on Monday, December 16th. Investors of record on Tuesday, December 17th will be given a dividend of $0.5147 per share on Friday, December 20th. This represents a $2.06 annualized dividend and a yield of 1.28%. The ex-dividend date is Monday, December 16th. View iShares US Pharmaceuticals ETF's Dividend History.

Has iShares US Pharmaceuticals ETF been receiving favorable news coverage?

News headlines about IHE stock have trended somewhat positive on Sunday, InfoTrie reports. The research firm rates the sentiment of news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. iShares US Pharmaceuticals ETF earned a coverage optimism score of 2.0 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for iShares US Pharmaceuticals ETF.

What other stocks do shareholders of iShares US Pharmaceuticals ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other iShares US Pharmaceuticals ETF investors own include Adobe (ADBE), Broadcom (AVGO), Baidu (BIDU), Biogen (BIIB), Brooks Automation (BRKS), Caesars Entertainment (CZR), Mylan (MYL), PepsiCo (PEP), Starbucks (SBUX) and Skyworks Solutions (SWKS).

Who are iShares US Pharmaceuticals ETF's key executives?

iShares US Pharmaceuticals ETF's management team includes the folowing people:
  • George G. C. Parker Ph.D., Independent Chairman of the Board of Trustees (Age 78)
  • Michael Arthur Latham, President, Trustee (Age 51)
  • Jack Gee, Chief Financial Officer, Treasurer (Age 57)
  • Geoffrey D. Flynn, Chief Operating Officer, Executive Vice President
  • Amy Schioldager, Executive Vice President (Age 56)
  • Ira P. Shapiro, Vice President, Chief Legal Officer (Age 52)
  • Matt Tucker, Vice President
  • Eilleen M. Clavere, Secretary (Age 61)
  • Cecilia H. Herbert, Independent Trustee (Age 68)
  • Charles A. Hurty, Independent Trustee (Age 73)

Who are iShares US Pharmaceuticals ETF's major shareholders?

iShares US Pharmaceuticals ETF's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Goldman Sachs Group Inc. (4.65%), Bank of America Corp DE (1.43%), Murphy Capital Management Inc. (1.04%), UBS Group AG (0.45%), Steward Partners Investment Advisory LLC (0.37%) and Envestnet Asset Management Inc. (0.34%).

Which major investors are selling iShares US Pharmaceuticals ETF stock?

IHE stock was sold by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., Raymond James & Associates, Murphy Capital Management Inc., First Allied Advisory Services Inc., Cetera Advisor Networks LLC, Patten & Patten Inc. TN, Advisor Group Inc. and Raymond James Financial Services Advisors Inc..

Which major investors are buying iShares US Pharmaceuticals ETF stock?

IHE stock was acquired by a variety of institutional investors in the last quarter, including Bank of America Corp DE, Orion Portfolio Solutions LLC, Jane Street Group LLC, Janney Montgomery Scott LLC, Steward Partners Investment Advisory LLC, Intl Fcstone Inc., Aft Forsyth & Company Inc. and Private Advisor Group LLC.

How do I buy shares of iShares US Pharmaceuticals ETF?

Shares of IHE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is iShares US Pharmaceuticals ETF's stock price today?

One share of IHE stock can currently be purchased for approximately $161.19.

How big of a company is iShares US Pharmaceuticals ETF?

iShares US Pharmaceuticals ETF has a market capitalization of $354.62 million. View Additional Information About iShares US Pharmaceuticals ETF.

What is iShares US Pharmaceuticals ETF's official website?

The official website for iShares US Pharmaceuticals ETF is http://www.iShares.com/.


MarketBeat Community Rating for iShares US Pharmaceuticals ETF (NYSEARCA IHE)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  34 (Vote Outperform)
Underperform Votes:  29 (Vote Underperform)
Total Votes:  63
MarketBeat's community ratings are surveys of what our community members think about iShares US Pharmaceuticals ETF and other stocks. Vote "Outperform" if you believe IHE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IHE will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/16/2020 by MarketBeat.com Staff

Featured Article: Penny Stocks

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel